CATALOGO DEI PRODOTTI DELLA RICERCA

IDOLAZZI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.226
NA - Nord America 4.629
AS - Asia 2.834
SA - Sud America 230
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 9
Totale 12.955
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.597
GB - Regno Unito 2.029
CN - Cina 1.556
SG - Singapore 976
IT - Italia 541
DE - Germania 526
SE - Svezia 468
RU - Federazione Russa 449
IE - Irlanda 386
FR - Francia 383
FI - Finlandia 238
BR - Brasile 197
UA - Ucraina 74
TR - Turchia 71
JP - Giappone 59
KR - Corea 49
NL - Olanda 31
BE - Belgio 28
HK - Hong Kong 28
VN - Vietnam 25
AT - Austria 21
CA - Canada 20
RO - Romania 15
IR - Iran 11
AR - Argentina 10
ID - Indonesia 9
EC - Ecuador 7
IN - India 7
AU - Australia 6
MX - Messico 6
QA - Qatar 6
CH - Svizzera 5
UZ - Uzbekistan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EG - Egitto 4
EU - Europa 4
TG - Togo 4
VE - Venezuela 4
ZA - Sudafrica 4
AZ - Azerbaigian 3
BD - Bangladesh 3
CL - Cile 3
CO - Colombia 3
ES - Italia 3
KG - Kirghizistan 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PE - Perù 3
PL - Polonia 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
BG - Bulgaria 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
HR - Croazia 2
IQ - Iraq 2
JO - Giordania 2
KE - Kenya 2
LT - Lituania 2
PK - Pakistan 2
PT - Portogallo 2
SI - Slovenia 2
TH - Thailandia 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
PY - Paraguay 1
SN - Senegal 1
SV - El Salvador 1
TM - Turkmenistan 1
Totale 12.955
Salva come PNG Salva come JPEG
Città #
Southend 1.927
Chandler 942
Singapore 608
Jacksonville 469
Woodbridge 390
Dublin 385
Ann Arbor 315
Ashburn 290
Beijing 251
Houston 205
Lawrence 160
Princeton 160
Wilmington 155
Jinan 144
Redmond 128
Shenyang 127
Bologna 126
Nanjing 122
Verona 101
Helsinki 94
New York 82
Hebei 73
Tianjin 64
Tokyo 53
Zhengzhou 53
Changsha 51
Haikou 51
Ningbo 51
Sindelfingen 43
Taizhou 41
Taiyuan 39
Milan 38
Nanchang 38
Hangzhou 34
Redwood City 34
Jiaxing 31
Guangzhou 29
Brussels 25
Los Angeles 25
Norwalk 25
Hong Kong 24
Lanzhou 24
Fuzhou 23
Boardman 22
Düsseldorf 21
Rome 21
Washington 21
Seattle 20
Dearborn 19
Sanayi 18
Santa Clara 17
São Paulo 17
Dallas 16
Lancaster 16
Vienna 16
Falls Church 15
Nürnberg 15
Orani 15
Fairfield 13
Moscow 13
San Francisco 13
Detroit 12
Toronto 12
Dong Ket 11
Venice 11
Chicago 10
Dongguan 9
Esslingen am Neckar 9
Florianópolis 9
Jakarta 9
Bârlad 7
Council Bluffs 7
Frankfurt am Main 7
Nuremberg 7
Porto Alegre 7
Seoul 7
Shanghai 7
Cagliari 6
Clearwater 6
Denver 6
Kemerovo 6
Kent 6
Rio de Janeiro 6
Seo-gu 6
Amsterdam 5
Auburn Hills 5
Brasília 5
Curitiba 5
London 5
Munich 5
Tashkent 5
The Dalles 5
Turin 5
Belo Horizonte 4
Brescia 4
Buenos Aires 4
Central 4
Easton 4
Lomé 4
Quito 4
Totale 8.614
Salva come PNG Salva come JPEG
Nome #
Teriparatide and denosumab combination therapy and skeletal metabolism 251
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 154
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 143
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 136
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 136
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 127
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 127
DXA bone mineral density in males: retrospective study in real life. 126
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 126
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 126
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 125
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 123
Bone metabolism in patients with anorexia nervosa and amenorrhoea 121
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 118
Prevalence and incidence of rheumatoid arthritis in Italy. 118
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 118
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 118
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 116
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 116
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 115
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 114
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 110
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 109
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 109
Vitamin D levels in patients with psoriasis with or without arthritis 108
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 108
Prevalence of osteoporosis in patients affected by mastocytosis 107
Osteopetrosi 106
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 106
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 106
Could γ\δ T-cells explain zoledronic acid adverse events? 105
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 104
Bone involvement in patient with clonal mast cell disorders 104
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 103
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 102
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 102
Bone involvement and osteoporosis in mastocytosis. 101
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 101
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 100
Periostin: The bone and beyond 100
Effects of denosumab on peripheral lymphocyte subpopulations 97
Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study 95
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 95
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 95
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 94
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 94
Drug-induced osteonecrosis of the jaw: the state of the art 94
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 94
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 94
Duration of treatment for osteoporosis 94
MEDAL con etoricoxib: l’inizio di una nuova era per il trattamento del dolore muscolo scheletrico 93
Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study. 93
Previous use of amino-bisphosphonates and circulating gamma/delta T cells 92
Sclerostin and DKK1 in primary hyperparathyroidism. 92
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 92
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 90
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 90
Strong relationship between vitamin D status and bone mineral density in anorexia nervosa 90
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. 89
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 89
The obesity paradox and osteoporosis 89
Long-term consequences of a treatment course with bisphosphonates in primary hyperparathyroidism 88
Focal bone involvement in inflammatory arthritis: the role of IL17 88
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 88
Variazione della densità minerale ossea ed attività antifratturativa; 88
Osteoporosi ed attività sportiva. 87
Osteoporosi ed attività sportiva: 86
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 86
Rheumatoid arthritis, γδ T cells and bisphosphonates 85
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 84
Vitamin D and rheumatic diseases. 84
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 84
Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake. 83
Seasonal and regional variations in the prevalence of vitamin D insufficiency in patiens with theumatoid arthritis 83
Zoledronic Acid in Osteoporosis Secondary to Mastocytosis. 83
Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease 83
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 82
Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight 81
Neridronic acid for the treatment of bone metabolic diseases 81
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 81
Ruolo della vitamina D 80
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE) 80
Variazione della densità minerale ossea ed attività antifratturativa. 79
Disease activity and left ventricular systolic function in rheumatoid arthritis 79
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) 79
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 79
The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1 78
Effects of secukinumab on serum adipocytokines: preliminary data 77
Development and First Validation of a Disease Activity Score for Gout 77
Quantitative chest computed tomography is associated with two prediction models of mortality in interstitial lung disease related to systemic sclerosis 77
Operator-independent quantitative chest computed tomography versus standard assessment of interstitial lung disease related to systemic sclerosis: A multi-centric study 76
Correction to: The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 76
Could nail and joint alterations make the difference between psoriatic arthritis and osteoarthritis during the ultrasonographic evaluation of the distal interphalangeal joints? 75
Relationship Between Increased Fecal Calprotectin Levels and Interstitial Lung Disease in Systemic Sclerosis 75
Clinical development of neridronate: potential for new applications. 75
Surgical Treatment of Symptomatic Aortic Aneurysm in a Patient with Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis: Case Report and Review of the Literature 74
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 74
Vitamin D status in patients with chronic plaque psoriasis 73
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 73
Vitamin D and fractures: a systematic review 72
Totale 9.823
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.903
article - articoli 49.191
book - libri 0
conference - conferenze 424
curatela - curatele 0
other - altro 288
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.806
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020339 0 0 0 0 0 0 0 0 0 98 79 162
2020/20211.377 188 285 40 255 182 122 20 43 81 11 107 43
2021/20221.206 93 347 7 62 54 29 24 65 81 24 85 335
2022/20232.688 191 289 242 491 213 650 45 145 291 30 76 25
2023/20241.251 54 113 107 152 158 180 60 126 6 37 189 69
2024/20252.065 152 221 152 493 145 111 163 147 472 9 0 0
Totale 13.287